SARS-CoV-2 / COVID-19 ELISA Kits
The effective detection of the coronavirus is essential. RT-PCR (Real-time polymerase chain reaction) tests are currently being used to detect genetic material to perform coronavirus testing. However, these tests have low specificity and sensitivity and carry risks related to sample collection and sample handling. These risks can be reduced by using IgG or IgM ELISA kits. IgM is the first immunoglobulin to be produced in response to an antigen and is primarily detected during the early onset of disease.1 IgG on the other hand is the most common immunoglobulin produced in response to an infection. Antibody titer is 4 times or higher than that of the acute phase. IgG often remains in the body over the long term. Clinicians and researchers use ELISA kits to estimate antibodies in samples of COVID-19 patients.
Thoroughly tested COVID-19 Immunoglobulin (IgG, IgM, IgA, IgE) Kits
We offer you a handpicked selection of proven quantitative SARS-CoV-2 ELISA Kits for the detection of COVID-19 immunoglobulins such as IgG and IgM in human serum or plasma. Quantitative measurement of immunoglobulins helps to understand kinectics of antibody response and the longevity of N, RBD and S1 antibodies. Furthermore it enables to draw conclusions about antibody level required for protection from reinfection and its duration. All kit advantages at one glance:
- Low Sample Volume (5µl)
- Short Incubation Time (100 min)
- Tested with NIBSC Panel Sera 20/B770
Our SARS-CoV-2 sandwich ELISA immunoglobulin kits have been extensively tested against anti-SARS-CoV-2 verification panel for serology assays 20/B770 from the National Institute for Biological Standards and Control (NIBSC). The panel contains 23 Anti-SARS-CoV-2 positive samples of varying reactivity and antibody composition & 14 Anti-SARS-CoV-2 negative samples provided by the WHO (Fig1). For more information please contact our customer service. Discover our kits down below.
- Quantitative detection of Anti-SARS-CoV-2 S1 IgM.
- For usage with Plasma and Serum.
- Detection Range 6.25 - 100 ng/mL
- Quantitative detection of Anti-SARS-CoV-2 S1 IgG.
- For usage with Plasma and Serum.
- Detection Range 25 - 200 ng/mL
SARS-CoV-2 Nucleocapsid (N) Protein ELISA Kits
- (1)
- (1)
- (1)
- (1)
SARS-CoV-2 Spike (S) Protein ELISA Kits
- (1)
- (1)
Our most popular COVID-19 ELISA Kit Products
- (1)
- (1)
- (1)
- (14)
- (5)
Other SARS-CoV-2 Kits
- (4)
- (4)
References
- Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y et al. (2020) "Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease." Pre-print medRxiv 2020.03.02.20030189.
- Ahn, Sohn, Lee, Cho, Hyun, Baek, Jeong, Kim, Ku, Yeom, Roh, Ahn, Chin, Kim, Lee, Yong, Kim, Kim, Choi: "Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea." in: Journal of Korean medical science, Vol. 35, Issue 14, pp. e149, 2020
- Krüttgen, Cornelissen, Dreher, Hornef, Imöhl, Kleines: "Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG." in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, Vol. 128, pp. 104394, 2020
- Bundschuh, Egger, Wiesinger, Gabriel, Clodi, Mueller, Dieplinger: "Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma." in: Clinica chimica acta; international journal of clinical chemistry, Vol. 509, pp. 79-82, 2020
- Egger, Bundschuh, Wiesinger, Gabriel, Clodi, Mueller, Dieplinger: "Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma." in: Clinica chimica acta; international journal of clinical chemistry, Vol. 509, pp. 18-21, 2020
Creative mind of antibodies-online with a keen eye for details. Proficient in the field of life-science with a passion for plant biotechnology and clinical study design. Responsible for illustrated and written content at antibodies-online as well as supervision of the antibodies-online scholarship program.
Go to author page
